Lonza expands cell and gene therapy portfolio
Lonza boosts TheraPEAK line with new Cytokines and AAV Medium for next-gen therapies
Lonza boosts TheraPEAK line with new Cytokines and AAV Medium for next-gen therapies
States exhorted to ensure rational use of cough syrups, particularly among children, as most coughs are self-limiting and do not require pharmacological treatment
It represents a 30% increase in the company’s production capacity and introduces a segment dedicated to highly potent active ingredients
Investment to expand manufacturing and global medicine supply capacity
The new algorithm will be introduced as part of Roche’s CKD Algorithm Panelon thenavify Algorithm Suite
Pioneering innovation aims to transform anticoagulant therapy and improve patient outcomes
Takeda will seek an external partner to leverage its cell therapy platform technologies
This agreement grants Vizient clients enhanced access to Natrelle, the broadest selection of breast implant options on the market
Subscribe To Our Newsletter & Stay Updated